rdpred-our-structure-placeholder-1920x750

How we do R&D

Over the past few years we have continuously improved the organisational and technological framework for cooperation between our Pharmaceuticals and Diagnostics Divisions. Although they have different Research & Development (R&D) processes, the two divisions can share research facilities, technologies and discoveries when working together on internal projects.

This is a unique advantage that sets Roche apart from other companies. Diagnostic tools are finding increasing use in pharmaceutical research. Most importantly, close cooperation is the basis for the successful implementation of our personalised healthcare strategy.

Three Pharma R&D units

To ensure a strong flow of suitable candidate molecules into its development pipeline, Roche has built a unique innovation network of independent Pharma research and development centers.

Pharma Research and Early Development (pRED), Genentech Research and Early Development (gRED) as well as Chugai in Japan operate independently within the group. Together with more than 150 partner organisations worldwide this network promotes a diversity of research approaches, as well as enabling access to new technologies and promising drug candidates.

Roche Pharma Research and Early Development (pRED)

Genentech Research and Early Development (gRED)

Chugai Pharmaceuticals, a member of the Roche Group

R&D in Six Diagnostics Business Areas

A healthcare pioneer and the industry’s global leader in in-vitro diagnostics, the Diagnostics Division pushes boundaries and challenges the status quo to redefine what’s possible. Our commitment to research and development means we can bring to the market integrated solutions in diagnostic testing, laboratory efficiency, healthcare digitalisation and decision support tools and software. Our products deliver increasingly precise information to help save lives, prevent or control the risk of infection and monitor treatment effectiveness.

The Roche Diagnostics Business Areas include Centralised and Point of Care Solutions (CPS), Molecular Diagnostics, Tissue Diagnostics, Sequencing, Diagnostics Information Solutions (DIS), and Diabetes Care. We have R&D facilities in the United States, Austria, Germany, Poland, Switzerland, South Africa and China.

Partnering with Roche

At Roche, we are passionate about science: yours and ours. Through partnerships we can build a better future together with medicines and diagnostics that make a real difference to patients.

Partnering with Pharma

Partnering with Diagnostics

rd_process_graph